LOS ANGELES (MarketWatch) -- Allergan Inc. and its activist investor, William Ackman, have settled a lawsuit over the triggering of Allergan's poison pill should a special meeting of the company's investors be held. The lawsuit, filed by Ackman's Pershing Square Capital Management, sought to keep the company from employing a poison pill on the basis of a special shareholder meeting to decide ...
[News Source]